Waltham, Massachusetts-based Thermo Fisher Scientific Inc. (TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. The company has a market cap of $217.5 billion and operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Shares of Thermo Fisher have slightly lagged behind the broader market over the past year, surging 20.3% compared to the S&P 500 Index’s ($SPX) 20.4% surge. Moreover, in 2026, the stock has grown by nearly 1.5%, also underperforming SPX’s 13.7% gain.